Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study — Sun Young Choi (2020) | RDL Network
Age-Dependent Anticoagulant Therapy for Atrial Fibrillation Patients with Intermediate Risk of Ischemic Stroke: A Nationwide Population-Based Study
Article 2020 en
Authors
SC
Sun Young Choi
MK
Moo Hyun Kim
KL
Kwang Min Lee
Abstract
1 min read
Age is an important determinant of ischemic stroke and composite outcome in intermediate-risk AF patients. The benefit of OAC therapy for these AF patients appears to have an age threshold (age ≥ 55 years).
Sun Young Choi, Moo Hyun Kim, Kwang Min Lee, Young‐Rak Cho, Jong Sung Park, Seong Woo Kim, Jin Kyung Kim, Matthew Chung, Sung‐Cheol Yun, Professor Gregory Lip
Pietro Caliandro, Virginia Cancelloni, M. De Marco, Giuseppe Reale, Aurelia Zauli, Giancarlo Agnelli, Valeria Caso, Cecilia Becattini, Paolo Calabresi, Maria Giulia Mosconi, Michela Giustozzi, Georgios Tsivgoulis, David Seiffge, Stefan T. Engelter, Philippe Lyrer, Alexandros A. Polymeris, Tolga Dittrich, Annaelle Zietz, Gian Marco De Marchis, Jukka Putaala, Daniel Strbian, Liisa Tomppo,
Discussion(0)
No comments yet. Be the first to comment.